[ad_1] The exports of the Indian pharmaceutical sector have witnessed a solid performance in the January to March quarter (Q4) of the 2024-25 fiscal year (FY25), with Contract Development and Manufacturing Organisations (CDMO) emerging as key growth drivers. According to Phillip Capital, the latest export data highlights robust momentum, particularly for companies engaged in producing […]